Papadakis MA, Elefsiniotis IS, Vlahos G, Daskalakis G, Barbatis C, Antsaklis A.
J Clin Virol. 2007 Feb;38(2):181-3. Epub 2006 Dec 4.
2) Passive-active immunoprophylaxis for all infants born from HBeAG-negative chronic HBV-infected mothers: Is it a cost-effective strategy?
Elefsiniotis IS, Papadakis MA, Vlahos G, Antsaklis A.
Hepatol Res. 2007 Jul;37(7):577-8.
3) Transforming a conventional theatre into a gynaecological endoscopy unit.
Anastasakis E, Protopapas A, Daskalakis G, Papadakis M, Milingos S, Antsaklis A.
Clin Exp Obstet Gynecol. 2007;34(2):99-101.
4) Maternal chronic hepatitis B virus is implicated with low neonatal paraoxonase/arylesterase activities.
Schulpis KH, Barzeliotou A, Papadakis M, Rodolakis A, Antsaklis A, Papassotiriou I, Vlachos GD.
Clin Biochem. 2008 Mar;41(4-5):282-7. Epub 2007 Nov 7.
5) Maternal chronic hepatitis B virus does not affect neonatal biotinidase activity.
Vlachos GD, Schulpis KH, Papakonstantinou E, Papadakis M, Elefsiniotis I, Papassotiriou I, Antsaklis A.
Acta Paediatr. 2008 Mar;97(3):362-5. Epub 2008 Jan 31.
6) Clinical significance of hepatitis B surface antigen in cord blood of hepatitis B e-antigen-negative chronic hepatitis B virus-infected mothers.
I.S.Elefsiniotis, M.Papadakis, G.Vlahos, G.Daskalakis, G.Saroglou, A.Antsaklis
Intervirology 25; 52 (3) : 132-134.